Stelfox, H. T., G. Chua, K. O’Rourke, and A. S. Detsky. 1998. Conflict of interest in the debate over calcium-channel antagonists. New England Journal of Medicine 338(2):101-106.
Steneck, N. H. 2006. ORI Introduction to the Responsible Conduct of Research. http://ori.hhs.gov/education/products/RCRintro/index.html (accessed August 3, 2011).
Stodden, V., and Yale Roundtable Participants. 2010. Reproducible research: Addressing the need for data and code sharing in computational science. Computing in Science and Engineering 12(5):8-13.
Taylor, C. F., D. Field, S.-A. Sansone, J. Aerts, R. Apweiler, M. Ashburner, C. A. Ball, P.-A. Binz, M. Bogue, T. Booth, A. Brazma, R. R. Brinkman, A. Michael Clark, E. W. Deutsch, O. Fiehn, J. Fostel, P. Ghazal, F. Gibson, T. Gray, G. Grimes, J. M. Hancock, N. W. Hardy, H. Hermjakob, R. K. Julian, M. Kane, C. Kettner, C. Kinsinger, E. Kolker, M. Kuiper, N. L. Novere, J. Leebens-Mack, S. E. Lewis, P. Lord, A.-M. Mallon, N. Marthandan, H. Masuya, R. McNally, A. Mehrle, N. Morrison, S. Orchard, J. Quackenbush, J. M. Reecy, D. G. Robertson, P. Rocca-Serra, H. Rodriguez, H. Rosenfelder, J. Santoyo-Lopez, R. H. Scheuermann, D. Schober, B. Smith, J. Snape, C. J. Stoeckert, K. Tipton, P. Sterk, A. Untergasser, J. Vandesompele, and S. Wiemann. 2008. Promoting coherent minimum reporting guidelines for biological and biomedical investigations: The MIBBI project. Nature Biotechnology 26(8):889-896.
Titus, S. L., J. A. Wells, and L. J. Rhoades. 2008. Repairing research integrity. Nature 453(7198):980-982.
TMQF Committee (Translational Medicine Quality Framework Committee). 2011. A Framework for the Quality of Translational Medicine with a Focus on Human Genomics Studies: Principles from the Duke Translational Medicine Quality Framework Committee. Durham, NC: Duke University.
Turner, E. H., A. M. Matthews, E. Linardatos, R. A. Tell, and R. Rosenthal. 2008. Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine 358(3):252-260.
van ‘t Veer, L. J., H. Dai, M. J. van de Vijver, Y. D. He, A. A. M. Hart, M. Mao, H. L. Peterse, K. van der Kooy, M. J. Marton, A. T. Wittereveen, G. J. Schreiber, R. M. Kerkoven, C. Roberts, P. S. Linsley, R. Bernards, and S. F. Friend. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(31):530-536.
Vedula, S. S., L. Bero, R. W. Scherer, and K. Dickersin. 2009. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. New England Journal of Medicine 361(20):1963-1971.
Vickers, A. 2008. Cancer data? Sorry, can’t have it. New York Times, January 22.
Wellcome Trust. 2011. Sharing Research Data to Improve Public Health: Full Joint Statement by Funders of Health Research. http://www.wellcome.ac.uk/About-us/Policy/Spotlight-issues/Data-sharing/Public-health-and-epidemiology/WTDV030690.htm (accessed August 11, 2011).
Yarborough, M., and R. R. Sharp. 2009. Public trust and research a decade later: What have we learned since Jesse Gelsinger’s death? Molecular Genetics and Metabolism 97(1):4-5.
Yarborough, M., K. Fryer-Edwards, G. Geller, and R. S. Sharp. 2009. Transforming the culture of biomedical research from compliance to trustworthiness: Insights from nonmedical sectors. Academic Medicine 84(4):472-476.
Zarin, D. A. 2005. Clinical trial registration. New England Journal of Medicine 352(15):1611.
Zarin, D. A., and T. Tse. 2008. Moving toward transparency of clinical trials. Science 319(5868):1340-1342.
Zarin, D. A., T. Tse, R. J. Williams, R. M. Califf, and N. C. Ide. 2011. The ClinicalTrials.gov results database—update and key issues. New England Journal of Medicine 364(9):852-860.